Developer docs
API playgroundTry for free, no card

Search company profiles

Cusabio Technology

Full company profile

uuid000fx27

Namestring
Cusabio Technology
Legal namestring
CUSABIO TECHNOLOGY LLC
Websiteurl
cusabio.com
Company typeenum
Private
Founded yearint
2007
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersHouston, United States
HQ citystring
Houston
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
life science reagents, recombinant proteins, antibody production, ELISA kits, contract research services
Industry2 codes
PRIMARYHLAGAAAB
Preclinical CROs (Discovery/Pharmacology/DMPK)
SECONDARYHLAGAAAD
Bioanalytical & Biomarker CROs (PK/PD/Immunogenicity)
NAICS code3 codes
  • In-Vitro Diagnostic Substance Manufacturing325413
  • Biological Product (except Diagnostic) Manufacturing325414
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
SIC code2 codes
  • In Vitro & In Vivo Diagnostic Substances2835
  • Biological Products, (No Disgnostic Substances)2836
Product category
Life Science Reagents
Social media profiles3 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Life Science Reagent Products
TypeOne Time License
Description

Sale of research reagents including ELISA kits (3000+ targets), recombinant proteins (15000+), antibodies (67000+), transmembrane proteins (470+), native proteins, peptides, molecular biology products, and small molecules. Products sold directly through e-commerce with 100% risk-free performance guarantee.

cusabio.com
2CRO Services
TypeProfessional Services
Description

Contract research organization services including protein expression services (E.coli, Yeast, Insect, Mammalian systems), therapeutic antibody discovery, custom antibody production, stable cell line development, peptide synthesis, SPR detection, gene synthesis, and oligo synthesis services.

cusabio.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Marketing or Sales, Supply Chain
Pricing details1 tier
1Plasmid DNA Purification Maxiprep Kit - US$140 for 5T*5
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Code: CSB-PPM02005; Sample: up to 200 mL bacterial cells; Yield: up to 1.5 mg of plasmid; Sizes: 5T, 5T*2, 5T*5

cusabio.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

CUSABIO Technology manufactures and sells life science research reagents including ELISA kits (3,000+ targets), recombinant proteins (15,000+), and antibodies (67,000+), produced using five proprietary expression systems. The company also operates a CRO services arm offering custom protein expression, therapeutic antibody discovery, phage display screening, stable cell line development, and peptide/gene/oligo synthesis for pharmaceutical, biotechnology, and academic customers globally.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • 31,000+ published citations in research papers including Nature, Science, Cell, Immunity, Nature Medicine
+3 more records
Product overview1 text field

CUSABIO is a life science research products company offering a comprehensive portfolio of biological reagents and CRO services. The core offerings include ELISA Kits (3000+ targets), Antibodies (67000+ total including Polyclonal, Monoclonal, and Recombinant), and Recombinant Proteins (15000+) expressed in five systems (E.coli, Yeast, Insect Baculovirus, Mammalian Cell, Cell-free). The company provides specialized products including Transmembrane Proteins (470+) using VLP, Detergent Micelle, and Nanodisc platforms, Exosome Isolation Kits, Plasmid DNA Purification Kits, and HCP Detection ELISA Kits for biopharmaceutical quality control. Supporting services include Therapeutic Antibody Discovery, Protein Expression Services, Phage Display, Stable Cell Line Development, and integrated solutions for ADC Development, CAR-T Therapy, and mRNA Vaccine Research. The product portfolio spans research reagents, custom services, and specialized solutions for drug discovery and development.

Product and service22 records
1ELISA Kits
CategoryImmunoassay Reagents
Description

Enzyme-linked immunosorbent assay kits for detection of protein targets in biological samples including serum, plasma, cell culture supernatant, and tissue lysates; over 3,000+ targets available covering multiple species, used by life science researchers for quantitative protein analysis.

2Recombinant Proteins
CategoryRecombinant Proteins
Description

Laboratory-produced proteins expressed in E. coli, Yeast, Insect Baculovirus, Mammalian cells, or cell-free systems; 15,000+ catalog products with validated bio-activity for drug discovery and basic research applications.

3Antibodies
CategoryAntibodies
Description

Comprehensive antibody portfolio of 67,000+ products including polyclonal (65,000+), monoclonal (1,000+), recombinant (1,100+), secondary, tag/control, and custom antibodies, validated for ELISA, WB, IHC, IF, IP, FC, and ChIP applications.

4Active Proteins
5Native Proteins
6Transmembrane Proteins
7Exosome Isolation Kits
8Plasmid DNA Purification Maxiprep Kit
9HCP Detection ELISA Kits
10Food Safety & Drug Residues ELISA Kits
11Protein Expression Services
12Therapeutic Antibody Discovery Service
13Custom Antibody Production Services
14Stable Cell Line Development Service
15Phage Display Service
16SPR Detection Service
17Peptide Synthesis Service
18Gene Synthesis Service
19Oligo Synthesis Service
20mRNA Vaccine Research Solutions
21ADC Development Solutions
22CAR-T Therapy Development Solutions
Scale indicator14 records

Each record includes

Type, Value, Description, Source

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Abcam (acquired by Danaher) is the dominant global antibody and life science reagent supplier. Directly comparable catalog breadth (antibodies, ELISA kits, proteins), overlapping customer base of academic and pharma researchers, and highly similar product positioning make it the closest direct peer to CUSABIO.

TypeDirect peer
Description

China-anchored recombinant protein and antibody supplier with strong catalog and CRO services. Highly comparable product mix (recombinant proteins, antibodies, ELISA kits) and similarly positioned for researchers and biotechs globally.

TypeDirect peer
Description

Global life science tools and CRO provider offering protein expression services, antibody discovery (phage display), peptide synthesis, gene synthesis, and oligo synthesis. Closely matches CUSABIO's combined catalog-plus-CRO model.

TypeDirect peer
Description

US-based antibody specialist focused on signaling pathway research with rigorously validated antibodies. Direct competitor in the antibody catalog space, especially for academic researchers in cell biology and signal transduction.

TypeBroad incumbent
Description

Diversified life science tools company offering proteins (R&D Systems), antibodies, and ELISA kits across multiple brands. Substantial scale and global reach make it a broad incumbent competing across most of CUSABIO's catalog.

TypeDirect peer
Description

Antibody and protein manufacturer best known for its catalog of polyclonal antibodies. Direct competitor in catalog antibodies, particularly in academic research channels where catalog citation competitiveness is central.

TypeBroad incumbent
Description

Largest life sciences tools supplier with deep catalog, including antibodies, proteins, ELISA kits, and CRO services. Broad incumbent competing across virtually all of CUSABIO's product categories.

TypeBroad incumbent
Description

Established life science instruments and reagents supplier offering antibodies, ELISA kits, and protein detection tools. Overlaps with CUSABIO across reagent categories within a broader instruments-led portfolio.

9Absolute Antibody
TypeEmerging player
Description

Recombinant antibody expression and engineering specialist offering custom antibody production services. Closely overlaps CUSABIO's custom/recombinant antibody CRO services and competitive in the recombinant antibody catalog.

TypeDirect peer
Description

China-anchored antibody manufacturer with global distribution and a comparable catalog of polyclonal and monoclonal antibodies. Similar origin and product mix make it a directly comparable catalog peer.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers6 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Cusabio Technology

Life Science Reagentscusabio.com

Cusabio Technology firmographics

Firmographics
Name
Cusabio Technology
Legal name
CUSABIO TECHNOLOGY LLC
Website
https://cusabio.com
Company type
Private
Founded year
2007
Operating status
Operating
Headcount range
11–50 employees
Ownership category
akta.pro rank

Cusabio Technology industry classification

Industry
Product category
Life Science Reagents
NAICS
In-Vitro Diagnostic Substance Manufacturing (325413), Biological Product (except Diagnostic) Manufacturing (325414), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
SIC
In Vitro & In Vivo Diagnostic Substances (2835), Biological Products, (No Disgnostic Substances) (2836)
akta.pro industry
PRIMARYHLAGAAAB
Preclinical CROs (Discovery/Pharmacology/DMPK)
SECONDARYHLAGAAAD
Bioanalytical & Biomarker CROs (PK/PD/Immunogenicity)

Keywords

  • Life science reagents
  • Recombinant proteins
  • Antibody production
  • ELISA kits
  • Contract research services

Where Cusabio Technology is headquartered

Location

Headquarters

HQ city
Houston
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Cusabio Technology business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales, Supply Chain

Revenue model

  1. Life Science Reagent Products: Sale of research reagents including ELISA kits (3000+ targets), recombinant proteins (15000+), antibodies (67000+), transmembrane proteins (470+), native proteins, peptides, molecular biology products, and small molecules. Products sold directly through e-commerce with 100% risk-free performance guarantee.
  2. CRO Services: Contract research organization services including protein expression services (E.coli, Yeast, Insect, Mammalian systems), therapeutic antibody discovery, custom antibody production, stable cell line development, peptide synthesis, SPR detection, gene synthesis, and oligo synthesis services.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goPlasmid DNA Purification Maxiprep Kit - US$140 for 5T*5

Go-to-market motion1 record

Distribution channels3 records

Marketing channels6 records

Cusabio Technology product offering

Product offering

Core offering

CUSABIO Technology manufactures and sells life science research reagents including ELISA kits (3,000+ targets), recombinant proteins (15,000+), and antibodies (67,000+), produced using five proprietary expression systems. The company also operates a CRO services arm offering custom protein expression, therapeutic antibody discovery, phage display screening, stable cell line development, and peptide/gene/oligo synthesis for pharmaceutical, biotechnology, and academic customers globally.

Product overview

CUSABIO is a life science research products company offering a comprehensive portfolio of biological reagents and CRO services. The core offerings include ELISA Kits (3000+ targets), Antibodies (67000+ total including Polyclonal, Monoclonal, and Recombinant), and Recombinant Proteins (15000+) expressed in five systems (E.coli, Yeast, Insect Baculovirus, Mammalian Cell, Cell-free). The company provides specialized products including Transmembrane Proteins (470+) using VLP, Detergent Micelle, and Nanodisc platforms, Exosome Isolation Kits, Plasmid DNA Purification Kits, and HCP Detection ELISA Kits for biopharmaceutical quality control. Supporting services include Therapeutic Antibody Discovery, Protein Expression Services, Phage Display, Stable Cell Line Development, and integrated solutions for ADC Development, CAR-T Therapy, and mRNA Vaccine Research. The product portfolio spans research reagents, custom services, and specialized solutions for drug discovery and development.

Differentiator

Problem solved

Functional benefit

Products and services

  • ELISA Kits Enzyme-linked immunosorbent assay kits for detection of protein targets in biological samples including serum, plasma, cell culture supernatant, and tissue lysates; over 3,000+ targets available covering multiple species, used by life science researchers for quantitative protein analysis.
  • Recombinant Proteins Laboratory-produced proteins expressed in E. coli, Yeast, Insect Baculovirus, Mammalian cells, or cell-free systems; 15,000+ catalog products with validated bio-activity for drug discovery and basic research applications.
  • Antibodies Comprehensive antibody portfolio of 67,000+ products including polyclonal (65,000+), monoclonal (1,000+), recombinant (1,100+), secondary, tag/control, and custom antibodies, validated for ELISA, WB, IHC, IF, IP, FC, and ChIP applications.
  • Active Proteins
  • Native Proteins
  • Transmembrane Proteins
  • Exosome Isolation Kits
  • Plasmid DNA Purification Maxiprep Kit
  • HCP Detection ELISA Kits
  • Food Safety & Drug Residues ELISA Kits
  • Protein Expression Services
  • Therapeutic Antibody Discovery Service
  • Custom Antibody Production Services
  • Stable Cell Line Development Service
  • Phage Display Service
  • SPR Detection Service
  • Peptide Synthesis Service
  • Gene Synthesis Service
  • Oligo Synthesis Service
  • mRNA Vaccine Research Solutions
  • ADC Development Solutions
  • CAR-T Therapy Development Solutions

Quantifiable outcome

  • 31,000+ published citations in research papers including Nature, Science, Cell, Immunity, Nature Medicine
  • +3 more outcomes

Companies that use Cusabio Technology

Customer profile

Named customers6 records

Segments4 records

Ideal customer profiles3 records

Cusabio Technology technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature6 records

Cusabio Technology partnerships and signals

Strategic signal

Scale indicators14 records

Recent moves6 records

Expansion highlights6 records

Cusabio Technology competitors and assessment

Company assessment

Direct peers

  • Abcam: Abcam (acquired by Danaher) is the dominant global antibody and life science reagent supplier. Directly comparable catalog breadth (antibodies, ELISA kits, proteins), overlapping customer base of academic and pharma researchers, and highly similar product positioning make it the closest direct peer to CUSABIO.
  • Sino Biological: China-anchored recombinant protein and antibody supplier with strong catalog and CRO services. Highly comparable product mix (recombinant proteins, antibodies, ELISA kits) and similarly positioned for researchers and biotechs globally.
  • GenScript Biotech: Global life science tools and CRO provider offering protein expression services, antibody discovery (phage display), peptide synthesis, gene synthesis, and oligo synthesis. Closely matches CUSABIO's combined catalog-plus-CRO model.
  • Cell Signaling Technology (CST): US-based antibody specialist focused on signaling pathway research with rigorously validated antibodies. Direct competitor in the antibody catalog space, especially for academic researchers in cell biology and signal transduction.
  • Proteintech: Antibody and protein manufacturer best known for its catalog of polyclonal antibodies. Direct competitor in catalog antibodies, particularly in academic research channels where catalog citation competitiveness is central.
  • ABclonal Technology: China-anchored antibody manufacturer with global distribution and a comparable catalog of polyclonal and monoclonal antibodies. Similar origin and product mix make it a directly comparable catalog peer.

Broad incumbents

  • Bio-Techne: Diversified life science tools company offering proteins (R&D Systems), antibodies, and ELISA kits across multiple brands. Substantial scale and global reach make it a broad incumbent competing across most of CUSABIO's catalog.
  • Thermo Fisher Scientific (Life Sciences): Largest life sciences tools supplier with deep catalog, including antibodies, proteins, ELISA kits, and CRO services. Broad incumbent competing across virtually all of CUSABIO's product categories.
  • Bio-Rad Laboratories: Established life science instruments and reagents supplier offering antibodies, ELISA kits, and protein detection tools. Overlaps with CUSABIO across reagent categories within a broader instruments-led portfolio.

Emerging players

  • Absolute Antibody: Recombinant antibody expression and engineering specialist offering custom antibody production services. Closely overlaps CUSABIO's custom/recombinant antibody CRO services and competitive in the recombinant antibody catalog.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

Cusabio Technology social profiles

Digital presence

Cusabio Technology financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Cusabio Technology leadership team

Management profile

Number of profiles

Profiles1 record

Cusabio Technology funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Cusabio Technology M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Cusabio Technology

What does Cusabio Technology do?

CUSABIO Technology manufactures and sells life science research reagents including ELISA kits (3,000+ targets), recombinant proteins (15,000+), and antibodies (67,000+), produced using five proprietary expression systems. The company also operates a CRO services arm offering custom protein expression, therapeutic antibody discovery, phage display screening, stable cell line development, and peptide/gene/oligo synthesis for pharmaceutical, biotechnology, and academic customers globally.

Is Cusabio Technology a public or private company?

Cusabio Technology is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Cusabio Technology founded?

Cusabio Technology was founded in 2007. It employs 11 to 50 people.

Where is Cusabio Technology based?

Cusabio Technology is headquartered in Houston, United States, in the North America region.

How does Cusabio Technology make money?

Two revenue lines are on record. Life Science Reagent Products are the primary driver. The others are CRO Services.

Who are Cusabio Technology's main competitors?

Direct peers on record are Abcam, Sino Biological, GenScript Biotech, Cell Signaling Technology (CST), Proteintech and ABclonal Technology. Broad incumbents are Bio-Techne, Thermo Fisher Scientific (Life Sciences) and Bio-Rad Laboratories. Absolute Antibody is listed as an emerging player.

Does Cusabio Technology have an API?

No public API is recorded for Cusabio Technology.

What industry is Cusabio Technology in?

Cusabio Technology's product category is Life Science Reagents. Its primary akta.pro industry code is HLAGAAAB, Preclinical CROs (Discovery/Pharmacology/DMPK), with a secondary code of HLAGAAAD, Bioanalytical & Biomarker CROs (PK/PD/Immunogenicity). Its NAICS code is 325413 and its SIC code is 2835.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals